Across TCGA pan-cancer cohorts, FAR1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FAR1 data layer compared with 21 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FAR1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated FAR1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, LSCC, and CCRCC are the cancer types where FAR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.886	0.681	.017	16	view →
LSCC	DFS	Median	III,IV	0.910	0.421	.007	15	view →
CCRCC	DFS	Tertile	III,IV	0.688	1.000	.015	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: FAR1 tumor-vs-normal RNA expression · all FAR1 data types